IMM 1.49% 34.0¢ immutep limited

a current prediction, page-117

  1. 2,542 Posts.
    lightbulb Created with Sketch. 301
    Merck in a statement said it is "continuously innovating to enhance the benefits of Keytruda in order to reach greater numbers of patients and to increase efficacy and convenience of the treatment."NewYork Feb23
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.